Clinical Trial Update: Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study [Phase 2]

View source ↗

Summary

A completed Phase 2 randomized trial evaluating the combination of nivolumab and relatlimab in advanced or metastatic soft-tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Relatlimab (relatlimab)
• nivolumab (nivolumab)

Snippet

Sponsor: Institut Bergonié | Conditions: Soft Tissue Sarcoma Adult, Advanced Cancer | Phase 2 | Status: COMPLETED